Inso Biosciences
Ithaca
About Inso Biosciences
Inso Biosciences is an early-stage biotechnology company developing hardware platforms and tools for genomic sample handling. Our patented microfluidic technology, invented and developed at Cornell University, performs high-efficiency processing of cellular material, and we are exploring applications in long-read DNA extraction, multiomic sample processing, and pathogen surveillance. To find out more, please visit our website: www.inso.bio To get in touch with us, please email: [email protected]
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Aug 2025)
- Website: inso.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/inso-biosciences-55701 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.